MNT Optimization for Intracellular Delivery of Antibody Fragments
- PMID: 29779097
- DOI: 10.1134/S1607672918020023
MNT Optimization for Intracellular Delivery of Antibody Fragments
Abstract
We studied the possibility of optimizing modular nanotransporters (MNTs) for the intracellular delivery of antibody fragments into the nuclei of cells of a specified type. Basic MNT with a reduced size retaining the desired functions was obtained, and the principal possibility of obtaining an MNT carrying an antibody fragment by microbiological synthesis was shown.
Similar articles
-
Development and evaluation of a new modular nanotransporter for drug delivery into nuclei of pathological cells expressing folate receptors.Drug Des Devel Ther. 2017 Apr 26;11:1315-1334. doi: 10.2147/DDDT.S127270. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28490863 Free PMC article.
-
Study of Biodistribution of the Modular Nanotransporters after Systemic Administration in Murine Cloudman S91 Melanoma Model.Dokl Biochem Biophys. 2018 Jan;478(1):55-57. doi: 10.1134/S1607672918010131. Epub 2018 Mar 14. Dokl Biochem Biophys. 2018. PMID: 29536312
-
Modular Nanotransporter with P21 Fragment Inhibits DNA Repair after Bleomycin Treatment.Dokl Biochem Biophys. 2018 Mar;479(1):95-97. doi: 10.1134/S1607672918020114. Epub 2018 May 19. Dokl Biochem Biophys. 2018. PMID: 29779106
-
Modular nanotransporters of anticancer drugs conferring cell specificity and higher efficiency.Biochemistry (Mosc). 2009 Dec;74(13):1567-74. doi: 10.1134/s0006297909130094. Biochemistry (Mosc). 2009. PMID: 20210709 Review.
-
Tailoring nanocarriers for intracellular protein delivery.Chem Soc Rev. 2011 Jul;40(7):3638-55. doi: 10.1039/c0cs00227e. Epub 2011 May 12. Chem Soc Rev. 2011. PMID: 21566806 Review.
Cited by
-
The Delivery of Biologically Active Agents into the Nuclei of Target Cells for the Purposes of Translational Medicine.Acta Naturae. 2020 Oct-Dec;12(4):47-56. doi: 10.32607/actanaturae.11049. Acta Naturae. 2020. PMID: 33456977 Free PMC article.
-
Targeted Intracellular Delivery of Antibodies: The State of the Art.Front Pharmacol. 2018 Oct 24;9:1208. doi: 10.3389/fphar.2018.01208. eCollection 2018. Front Pharmacol. 2018. PMID: 30405420 Free PMC article. Review.
-
Demonstration of intracellular trafficking, cytosolic bioavailability, and target manipulation of an antibody delivery platform.Nanomedicine. 2021 Feb;32:102315. doi: 10.1016/j.nano.2020.102315. Epub 2020 Oct 13. Nanomedicine. 2021. PMID: 33065253 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials